ARCHIVES

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

This article is from The Cancer Letter archive.

Vol. 05 No. 11 | March 16, 1979

Download PDF Visit The Full Archive

Related Articles

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999